PROM1 and pancreatic ductal adenocarcinoma: Pancreatic ductal adenocarcinoma patients with the expression of cMet+ CD45+ CD34+CD133 Ter119, CD44, Pdx1, CD13, CD9, CD133, and CD24 had a poor prognosis (PDAC).